ROS, as one of the most important metabolites after GPx2 knockdown, modulates the tumor microenvironment, affecting various stromal cells that provide metabolic support, blood supply, tumor immune response and tumor metastasis [33]. The gene discussed is GPX2; the disease is neoplasm.